Variant report
Variant | nsv1040362 |
---|---|
Chromosome Location | chr10:56577036-56622686 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:3 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs569223319 | chr10:56577044-56577045 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs78410015 | chr10:56577059-56577060 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs142119121 | chr10:56577088-56577089 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs538442431 | chr10:56577100-56577101 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs192800833 | chr10:56577120-56577121 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs540068513 | chr10:56577133-56577134 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs553634921 | chr10:56577231-56577232 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs554057704 | chr10:56577255-56577256 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs577083856 | chr10:56577279-56577280 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs545455551 | chr10:56577289-56577290 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs55925661 | chr10:56577341-56577342 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs535335377 | chr10:56586800-56586801 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs558528282 | chr10:56586808-56586809 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs571647436 | chr10:56586811-56586812 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs537476513 | chr10:56586831-56586832 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs147243997 | chr10:56586846-56586847 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs374991921 | chr10:56586878-56586879 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs570823833 | chr10:56586895-56586896 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs138683598 | chr10:56586901-56586902 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs553662159 | chr10:56586946-56586947 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs73254004 | chr10:56586955-56586956 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
22 | rs77650240 | chr10:56586964-56586965 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs181876021 | chr10:56586966-56586967 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs544902193 | chr10:56586980-56586981 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs564861795 | chr10:56586991-56586992 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs115002093 | chr10:56594445-56594446 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs553942508 | chr10:56594473-56594474 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs561401250 | chr10:56594484-56594485 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs180974012 | chr10:56594511-56594512 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs573440018 | chr10:56594536-56594537 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs545638076 | chr10:56594573-56594574 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs565524619 | chr10:56594585-56594586 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs531117947 | chr10:56594593-56594594 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs530193484 | chr10:56594648-56594649 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs148406726 | chr10:56594701-56594702 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs75847919 | chr10:56594733-56594734 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs546922668 | chr10:56594897-56594898 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs560147487 | chr10:56594916-56594917 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs560748970 | chr10:56594925-56594926 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs185963425 | chr10:56594954-56594955 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs546676216 | chr10:56595012-56595013 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs566642080 | chr10:56595043-56595044 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs532148376 | chr10:56595046-56595047 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs142501287 | chr10:56595063-56595064 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs113247071 | chr10:56595078-56595079 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs149856373 | chr10:56595161-56595162 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs537740576 | chr10:56595172-56595173 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs554875665 | chr10:56595180-56595181 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs369437108 | chr10:56595199-56595200 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs10430482 | chr10:56595219-56595220 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Pancreatic endocrine tumor | 17639061 | CNVD |
Gastric cancer | 17908304 | CNVD |
Chordoma | 21602918 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Melanoma | 18172304 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 20724749 | CNVD |
Autism | 22495311 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Prostate cancer | 18632612 | CNVD |
Autism | 18414403 | CNVD |
Cockayne syndrome | 18421352 | CNVD |
Glioblastoma | 16823260 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Neuroblastoma | 17533364 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Glioma | 21971842 | CNVD |
Cancer | 21637783 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Obesity | 21956041 | CNVD |
Developmental delay | 21948486 | CNVD |
Intellectual disability | 21948486 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21364760 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Autism | 20841430 | CNVD |
Mental retardation | 17124404 | CNVD |
Epilepsy | 20923578 | CNVD |
Prostate cancer | 16573809 | CNVD |
Schizophrenia | 19329560 | CNVD |
Heart failure | 18772530 | CNVD |
Heart failure | 18854381 | CNVD |
Hyperglycemia | 19060297 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Usher syndrome | 20538994 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Autism | 20858243 | CNVD |
Breast cancer | 22522925 | CNVD |
Usher type I cohort | 17277737 | CNVD |
Usher type I cohort | 21436283 | CNVD |
Leukemia | 21357790 | CNVD |
Medulloblastoma | 22832581 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
early-passage human iPS cells | 21368824 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr10:56576400-56577400 | Enhancers | NHEK | skin |
2 | chr10:56586800-56587000 | Enhancers | Pancreas | Pancrea |
3 | chr10:56594400-56595400 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
4 | chr10:56594600-56595400 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
5 | chr10:56600800-56601400 | Enhancers | HUES48 Cell Line | embryonic stem cell |
6 | chr10:56601400-56606200 | Weak transcription | HUES48 Cell Line | embryonic stem cell |
7 | chr10:56602200-56603200 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
8 | chr10:56602600-56603200 | Enhancers | Breast Myoepithelial Primary Cells | Breast |
9 | chr10:56602600-56603400 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
10 | chr10:56602600-56603800 | Enhancers | Fetal Brain Female | brain |
11 | chr10:56602600-56604400 | Enhancers | Fetal Heart | heart |
12 | chr10:56602800-56603200 | Active TSS | Left Ventricle | heart |
13 | chr10:56602800-56603800 | Active TSS | Right Ventricle | heart |
14 | chr10:56603200-56606400 | Weak transcription | Breast Myoepithelial Primary Cells | Breast |
15 | chr10:56603400-56606800 | Weak transcription | Foreskin Keratinocyte Primary Cells skin03 | Skin |
16 | chr10:56606200-56606600 | Enhancers | HUES48 Cell Line | embryonic stem cell |
17 | chr10:56606400-56606800 | Enhancers | Breast Myoepithelial Primary Cells | Breast |
18 | chr10:56606800-56607800 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
19 | chr10:56611400-56611600 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
20 | chr10:56611600-56615000 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |
21 | chr10:56613600-56614000 | ZNF genes & repeats | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
22 | chr10:56615000-56615200 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |